Biao He
Direktor/Vorstandsmitglied bei BioEclipse Therapeutics, Inc.
Aktive Positionen von Biao He
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Biao He
Ehemalige bekannte Positionen von Biao He
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tsinghua Silicon Valley Capital
Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Private Equity Investor | - | - |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Tsinghua Silicon Valley Capital
Tsinghua Silicon Valley Capital Investment ManagersFinance Tsinghua Silicon Valley Capital (TEEC Angel Management) is a venture capital firm founded in 2010 by Eugene Zhang and Chun Xia. The firm is headquartered in Los Altos, California. | Finance |
BioEclipse Therapeutics, Inc.
BioEclipse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology BioEclipse Therapeutics, Inc. engages in the development of curative immune-oncology therapeutics for patient with cancer. Its patented immunotherapy is the CRX-100, which delivers potentially curative treatments to patients over a broad range of tumor type. The company was founded by Pamela R. Contag, Christopher Contag, and Robert Negrin and is headquartered in San Francisco, CA. | Health Technology |